RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to KIF11

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
FILANESIB	Small molecule	acute myeloid leukemia	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	gastric cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	prostate adenocarcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
FILANESIB	Small molecule	multiple myeloma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	non-small cell lung carcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
FILANESIB	Small molecule	myelodysplastic syndrome	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	cutaneous melanoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
FILANESIB	Small molecule	multiple myeloma	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	rectum cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	leukemia	Kinesin-like protein 1 inhibitor	1.0	Terminated	ClinicalTrials
AZD-4877	Small molecule	lymphoma	Kinesin-like protein 1 inhibitor	1.0	Terminated	ClinicalTrials
FILANESIB	Small molecule	neoplasm	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	metastatic malignant neoplasm	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
AZD-4877	Small molecule	carcinoma	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	liver cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	malignant colon neoplasm	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
FILANESIB	Small molecule	plasma cell leukemia	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	breast neoplasm	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	ovarian cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	head and neck malignant neoplasia	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	breast cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	neoplasm	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	renal cell carcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	esophageal cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
AZD-4877	Small molecule	acute myeloid leukemia	Kinesin-like protein 1 inhibitor	1.0	Terminated	ClinicalTrials
ISPINESIB	Small molecule	cancer	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
AZD-4877	Small molecule	non-Hodgkins lymphoma	Kinesin-like protein 1 inhibitor	1.0	Terminated	ClinicalTrials
LITRONESIB	Small molecule	colorectal carcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	prostate cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	ovarian cancer	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
ISPINESIB	Small molecule	breast neoplasm	Kinesin-like protein 1 inhibitor	1.0	Terminated	ClinicalTrials
ISPINESIB	Small molecule	non-small cell lung carcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	cancer	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
AZD-4877	Small molecule	neoplasm	Kinesin-like protein 1 inhibitor	1.0	Completed	ClinicalTrials
LITRONESIB	Small molecule	small cell lung carcinoma	Kinesin-like protein 1 inhibitor	2.0	Completed	ClinicalTrials

Welcome to

RBP World!

Drugs target to KIF11

Targets details